Verisyse intraocular lens implantation in a child with anisometropic amblyopia: Four-year follow-up

• Published in: Journal of cataract and refractive surgery Vol. 33; no. 11; pp. 1985 - 1986
• Main Authors: Assil, Kerry K., MD, Sturm, Julie M., MD, Chang, Steve H., MD
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.11.2007; Elsevier Science
• Subjects: Amblyopia - surgery; Anisometropia - surgery; Biological and medical sciences; Cell Count; Child, Preschool; Endothelium, Corneal - pathology; Follow-Up Studies; Humans; Lens Implantation, Intraocular; Male; Medical sciences; Myopia - surgery; Ophthalmology; Phakic Intraocular Lenses; Refraction, Ocular - physiology; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Surgery of the eye and orbit; Vision disorders; Visual Acuity - physiology; Human; Anisometropía; Eye disease; Treatment; Vision disorder; Surgery; Refractive error; Amblyopia; Implantation; Ophthalmology; Intraocular lens; Child
• ISSN: 0886-3350; 1873-4502
• DOI: 10.1016/j.jcrs.2007.06.038

A Verisyse phakic intraocular lens (pIOL) (AMO) was implanted in the eye of a 3-year-old child with unilateral high myopia and suspected dense amblyopia. Four years postoperatively, the Snellen visual acuity was 20/30 with a refraction of −1.00 −1.00 × 77 and the endothelial cell density was 3262 cells/mm2 compared with 3092 cells/mm2 in the right eye. The Verisyse pIOL may be a treatment option to prevent dense amblyopia in children with highly myopic anisometropia.